-1753895472875.webp&w=3840&q=75)
2025 NOSCM | The Complexity of Treatment Options for DLBCL: Novel Antibodies and CAR-T Cell Therapy
Overview
Dr. Matthew Lunning discussed DLBCL treatment, highlighting novel antibodies and CAR-T therapy. Future options include Glofit-Pola and next-gen CAR-Ts.
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Matthew Lunning, DO, FACP
Date of Release
July 30th, 2025
-1753895653633.webp&w=3840&q=75)
-1753895561853.webp&w=3840&q=75)